| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36415 |
Collection of venous blood by venipuncture |
17,664 |
14,505 |
$1.34M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
44,273 |
41,040 |
$1.22M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,067 |
14,915 |
$661K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,495 |
8,924 |
$652K |
| 87430 |
|
2,773 |
2,686 |
$598K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,325 |
3,834 |
$427K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,727 |
1,444 |
$334K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,381 |
3,260 |
$273K |
| 87077 |
|
3,375 |
3,135 |
$226K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,766 |
2,520 |
$183K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,600 |
936 |
$179K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,299 |
7,802 |
$144K |
| 81003 |
|
4,920 |
4,587 |
$107K |
| 80053 |
Comprehensive metabolic panel |
8,801 |
7,680 |
$97K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,905 |
3,697 |
$84K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,523 |
1,424 |
$78K |
| 87088 |
|
2,393 |
2,241 |
$65K |
| 71045 |
Radiologic examination, chest; single view |
4,417 |
4,065 |
$63K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,812 |
2,607 |
$55K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
992 |
900 |
$48K |
| 73610 |
|
578 |
527 |
$46K |
| 73630 |
|
615 |
570 |
$43K |
| 81025 |
|
2,902 |
2,742 |
$37K |
| 87807 |
|
180 |
176 |
$34K |
| 71046 |
Radiologic examination, chest; 2 views |
1,856 |
1,640 |
$33K |
| 81000 |
|
2,003 |
1,763 |
$33K |
| 81001 |
|
2,411 |
2,173 |
$29K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,829 |
2,261 |
$29K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,763 |
5,967 |
$28K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,527 |
1,394 |
$26K |
| J3490 |
Unclassified drugs |
638 |
363 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,537 |
1,490 |
$24K |
| 87070 |
|
1,775 |
1,716 |
$22K |
| 73030 |
|
357 |
324 |
$21K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,576 |
2,357 |
$18K |
| 73130 |
|
203 |
184 |
$17K |
| 73110 |
|
204 |
185 |
$17K |
| 73564 |
|
427 |
378 |
$15K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,303 |
1,171 |
$15K |
| 82962 |
|
411 |
293 |
$12K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
105 |
98 |
$10K |
| 72100 |
|
258 |
244 |
$9K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
707 |
663 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
408 |
389 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,876 |
3,454 |
$6K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
140 |
138 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,012 |
1,362 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
29 |
24 |
$6K |
| 85027 |
|
10,705 |
9,494 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,079 |
1,632 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,840 |
4,174 |
$3K |
| 73562 |
|
76 |
65 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
87 |
83 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,350 |
1,924 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
377 |
339 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
169 |
152 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
55 |
52 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
27 |
27 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
540 |
522 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,790 |
1,634 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,339 |
1,992 |
$1K |
| 83735 |
|
1,681 |
1,374 |
$920.20 |
| G0378 |
Hospital observation service, per hour |
26 |
14 |
$903.37 |
| 94760 |
|
1,477 |
1,062 |
$833.26 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
27 |
24 |
$823.10 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
571 |
549 |
$755.66 |
| 82150 |
|
3,675 |
3,286 |
$565.56 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,811 |
1,535 |
$446.21 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
12 |
12 |
$394.86 |
| 80076 |
|
2,528 |
2,364 |
$393.60 |
| 74019 |
|
12 |
12 |
$371.08 |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,588 |
2,441 |
$315.21 |
| 80061 |
Lipid panel |
2,261 |
2,130 |
$308.68 |
| 70486 |
|
15 |
13 |
$239.40 |
| 73502 |
|
13 |
13 |
$160.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,005 |
2,708 |
$148.23 |
| 84484 |
|
3,332 |
2,611 |
$138.96 |
| 74021 |
|
34 |
26 |
$124.77 |
| 85379 |
|
926 |
880 |
$121.80 |
| A9270 |
Non-covered item or service |
3,056 |
2,555 |
$102.76 |
| 81002 |
|
27 |
26 |
$90.69 |
| 97161 |
|
13 |
13 |
$66.89 |
| 83690 |
|
4,211 |
3,756 |
$42.52 |
| 71020 |
|
19 |
13 |
$40.20 |
| 83880 |
|
252 |
230 |
$39.26 |
| 85610 |
|
1,045 |
880 |
$17.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,532 |
1,432 |
$9.65 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
3,451 |
2,985 |
$2.84 |
| 87040 |
|
734 |
481 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,116 |
1,013 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
317 |
282 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
134 |
132 |
$0.00 |
| 85730 |
|
640 |
589 |
$0.00 |
| 83605 |
|
811 |
695 |
$0.00 |
| 96376 |
|
116 |
76 |
$0.00 |
| 86140 |
|
30 |
28 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
70 |
61 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
12 |
$0.00 |
| 82607 |
|
14 |
12 |
$0.00 |
| 74022 |
|
32 |
30 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
27 |
24 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
17 |
14 |
$0.00 |
| 85651 |
|
28 |
27 |
$0.00 |
| 87205 |
|
15 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
504 |
433 |
$0.00 |
| 87186 |
|
910 |
821 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
298 |
290 |
$0.00 |
| 99218 |
|
13 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14 |
13 |
$0.00 |
| 86703 |
|
35 |
29 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
32 |
14 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
39 |
12 |
$0.00 |
| 84439 |
|
40 |
38 |
$0.00 |
| J0595 |
Injection, butorphanol tartrate, 1 mg |
132 |
124 |
$0.00 |
| 80074 |
|
31 |
27 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
57 |
51 |
$0.00 |
| 87075 |
|
15 |
13 |
$0.00 |